Properties (67)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:advertising |
partnerships
growth-oriented |
| gptkbp:businessModel |
active
biotech startup |
| gptkbp:campaigns |
various
|
| gptkbp:clinicalTrials |
gptkb:United_States
Phase 1 advanced innovative safety and efficacy diverse populations tumor microenvironment promising Phase 1, Phase 2, Phase 3 encouraging Phase 1, Phase 2 |
| gptkbp:collaborates_with |
research hospitals
|
| gptkbp:collaborations |
non-profit organizations
academic institutions |
| gptkbp:community_engagement |
healthcare_initiatives
|
| gptkbp:competitors |
comprehensive
|
| gptkbp:employeeCount |
50-100
|
| gptkbp:focus |
immuno-oncology
|
| gptkbp:founded |
2013
|
| gptkbp:founder |
gptkb:Dr._R._Scott_Greer
|
| gptkbp:funding |
various
grants |
| gptkbp:future_plans |
expand product pipeline
expand into new markets |
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Flexus Biosciences
|
| gptkbp:investmentFocus |
active
Venture capital firms |
| gptkbp:leadership |
gptkb:Dr._R._Scott_Greer
|
| gptkbp:market |
growing
biopharmaceuticals |
| gptkbp:notable_event |
development_of_IDO1_inhibitors
|
| gptkbp:notableFeature |
notable
|
| gptkbp:partnerships |
gptkb:Bristol-Myers_Squibb
strategic alliances |
| gptkbp:patentCitation |
biotechnology innovations
|
| gptkbp:platforms |
small molecule drugs
|
| gptkbp:productLine |
diverse
|
| gptkbp:products |
ongoing
F001 F002 |
| gptkbp:publications |
peer-reviewed journals
|
| gptkbp:regulatoryCompliance |
gptkb:FDA
frequent |
| gptkbp:research |
ongoing
clinical trials collaborative engaged |
| gptkbp:research_areas |
autoimmune diseases
cancer treatment combination therapies F001, F002 |
| gptkbp:research_focus |
immune response
|
| gptkbp:researchAndDevelopment |
positive
|
| gptkbp:social_responsibility |
sustainability efforts
|
| gptkbp:supportRole |
experts in oncology
|
| gptkbp:technology |
pharmaceutical companies
immune checkpoint inhibitors |
| gptkbp:updates |
regular
|
| gptkbp:website |
www.flexusbiosciences.com
|